docrishabhsingh's profile picture. Heme/Onc Fellow PGY-4 @IUHemOnc | IM via @UICOMPeoria| MBBS @NairTnmc | @HTRSfellows Council 2024-2026 | Passionate about #ClassicalHeme🩸| He/Him/His |

Rishabh Singh, MD 🩸

@docrishabhsingh

Heme/Onc Fellow PGY-4 @IUHemOnc | IM via @UICOMPeoria| MBBS @NairTnmc | @HTRSfellows Council 2024-2026 | Passionate about #ClassicalHeme🩸| He/Him/His |

固定されたツイート

Absolutely thrilled to be serving in the Clinical Fellows Network Council for the 2024-2026 term! @HTRStoday @HTRSFellows @hemeoncfellow @heme_fan @Clot1 @JonRob08 @rushadpatell @BloodClotDoc @DrSamelsonJones @ShubhAgrawalMD @AyeshaButtMD @lauren_amos17

docrishabhsingh's tweet image. Absolutely thrilled to be serving in the Clinical Fellows Network Council for the 2024-2026 term! @HTRStoday @HTRSFellows @hemeoncfellow 
@heme_fan @Clot1 @JonRob08 @rushadpatell @BloodClotDoc @DrSamelsonJones @ShubhAgrawalMD @AyeshaButtMD @lauren_amos17

Rishabh Singh, MD 🩸 さんがリポスト

New episode of “Don’t Just Read the Abstract” out now! In Episode 25, @PipNicolson & I discuss the BASIS trial of the TFPI inhibitor marstacimab in severe haemophilia A/B. Lots of critical appraisal points, including trial ethics and the Hawthorne effect. Great, digestible CPD!

richardbuka's tweet image. New episode of “Don’t Just Read the Abstract” out now! In Episode 25, @PipNicolson & I discuss the BASIS trial of the TFPI inhibitor marstacimab in severe haemophilia A/B. 

Lots of critical appraisal points, including trial ethics and the Hawthorne effect. Great, digestible CPD!

Rishabh Singh, MD 🩸 さんがリポスト

Amazing work from my friend Stephen Hibbs in @BloodPortfolio along with an allstar international cast - defining reference neutrophil ranges in Duffy null. Vital work to fight against systematic discrimination of ppl with Duffy null in cancer care & research among others.

richardbuka's tweet image. Amazing work from my friend Stephen Hibbs in @BloodPortfolio along with an allstar international cast - defining reference neutrophil ranges in Duffy null. Vital work to fight against systematic discrimination of ppl with Duffy null in cancer care & research among others.
richardbuka's tweet image. Amazing work from my friend Stephen Hibbs in @BloodPortfolio along with an allstar international cast - defining reference neutrophil ranges in Duffy null. Vital work to fight against systematic discrimination of ppl with Duffy null in cancer care & research among others.

I dream of a day when we can predict and prevent every clot!


Rishabh Singh, MD 🩸 さんがリポスト

Prolonged PT/PTT in cyanotic heart disease often calls for a heme consult. However, it is important to recognize that due to high hematocrit, often above 65% leads to less plasma in the tube causing altered plasma-anticoagulant ratio in the blue top tube and falsely high PT/PTT.


These tables should be in our (and everyone's) fellow survival guide @IUHemOnc!

Announcing the MAGIC-ONC guidelines for the placement and management of vascular access devices in patients with cancer, including specific recommendations for both hematologic and solid tumor malignancies. #MAGICOnc #onctwitter acpjournals.org/doi/epdf/10.73…



Rishabh Singh, MD 🩸 さんがリポスト

The scientific articles that end up published are the tip of an iceberg of hard work. This includes the dedication of selfless reviewers who sacrifice precious time to promote good science. To those that agree to review, with passion & care: Thanks. You make the world better.


Rishabh Singh, MD 🩸 さんがリポスト

H-1B visa–sponsored physicians are twice as prevalent in rural counties and nearly 4 times as common in high-poverty areas, highlighting the potential harm of rising visa costs to health care access. ja.ma/47xKm6F

JAMA_current's tweet image. H-1B visa–sponsored physicians are twice as prevalent in rural counties and nearly 4 times as common in high-poverty areas, highlighting the potential harm of rising visa costs to health care access. 

ja.ma/47xKm6F

Rishabh Singh, MD 🩸 さんがリポスト

Today in @NEJM_AI : Chris Mansi and I lay out our vision for redesigning clinical workflows with Generative AI. We build on our decade of work across 1,800 hospitals and use our chart summarization tool (Viz Assist) as one illustrative example for a path forward. "We have both…

AndrewMIbrahim's tweet image. Today in @NEJM_AI : Chris Mansi and I lay out our vision for redesigning clinical workflows with Generative AI. We build on our decade of work across 1,800 hospitals and use our chart summarization tool (Viz Assist) as one illustrative example for a path forward. 

"We have both…

Rishabh Singh, MD 🩸 さんがリポスト

On one of my first rotations as a med student, I presented a patient who was “on dialysis.” The attending asked, “What kind of dialysis?” I didn’t know because I had no idea there was more than one type. She looked down, shook her head, and told me to go read about dialysis and…


Loading...

Something went wrong.


Something went wrong.